Company: SMNR
Filing Date: 2025-08-15
Form Type: 10-Q
Source: 0001213900-25-077047
Chunk: 234

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-15
Form: 10-Q
Item: Part II, Item 5
Chunk 234
---
Item
5. OTHER INFORMATION.

None.

37

Item
6. EXHIBITS.

The following exhibits are filed as part of, or
incorporated by reference into, this Quarterly Report on Form 10-Q.

    No.
     
    Description of Exhibit
  
    31.1**
     
    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  
    31.2**
     
    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  
    32.1***
     
    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  
    32.2***
     
    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  
    101.INS**
     
    Inline XBRL Instance Document.
  
    101.SCH**
     
    Inline XBRL Taxonomy Extension Schema Document.
  
    101.CAL**
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.
  
    101.DEF**
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.
  
    101.LAB**
     
    Inline XBRL Taxonomy Extension Labels Linkbase Document.
  
    101.PRE**
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.
  
    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

    **
    Filed herein.

    ***
    Furnished herein.

38

Part
III. SIGNATURES

Pursuant to the requirements of Securities Exchange
Act of 1934, as amended, the registrant has duly caused this